GlassScriptPhysician profile
Kenneth Weinlander
NPI 1003233255
$1,031.93
in general payments reported to CMS, 2019-2025
15 companies · $91.49 in 2025
The $91.49 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2020: $142 · 2021: $60.59 · 2022: $62.29 · 2023: $155 · 2024: $240 · 2025: $91.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $485.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $153.68 | 2023-2024 | Xen Glaucoma Treatment System |
| Alcon Vision LLC | $146.26 | 2020-2024 | Hydrus Microstent |
| Biotissue Holdings INC. | $123.33 | 2020-2025 | |
| Shire North American Group INC | $102.18 | 2019 | |
| Rayner Intraocular Lenses Limited | $96.79 | 2022-2024 | Rayone Aspheric, Rayone Spheric, Omidria |
| Dompe US, INC. | $87.62 | 2019-2025 | Oxervate |
| Rxsight INC | $71.76 | 2023-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Carl Zeiss Meditec, INC. | $64.71 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $44.59 | 2024 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $43.06 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $26.91 | 2025 | |
| Astellas Pharma US INC | $22.41 | 2024 | Izervay |
| Sight Sciences, INC. | $17.69 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Glaukos Corporation | $15.59 | 2021 | |
| New World Medical,INC. | $15.35 | 2025 | Streamline, Clearpath, Via360 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Weinlander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.